BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Berlex Inc. (Acquired by Bayer AG in 2006) 

Press releases archived for reference only.
2600 Hilltop Drive
Richmond  California  94806  U.S.A.
Phone: 510-262-5000 Fax:


SEARCH JOBS








 Company News
Onmark Signs Exclusive Contracts with Pfizer Inc. (PFE) and Berlex for Oncology and Supportive Care Products 4/3/2007 10:53:23 AM    More...
Berlex Inc. Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment 4/2/2007 11:23:54 AM    More...
Biotech Industry is Down, for Now -- Berlex Inc. (Jobs) Plans to Eliminate 210 East Bay Jobs 3/20/2007 2:27:30 AM    More...
Favrille, Inc. (FVRL) Announces Agreement With Berlex Inc. Regarding Use Of FavId(R) In Combination With Leukine(R) (sargramostim) In B-Cell Non-Hodgkin's Lymphoma 2/14/2007 12:54:38 PM    More...
Berlex Inc. And Premier, Inc. Sign New Agreement For Magnetic Resonance Contrast Media 1/4/2007 12:06:16 PM    More...
FDA Approves Berlex Inc.'s Betaseron(R) For Use After The First Event Suggestive Of Multiple Sclerosis 10/23/2006 11:27:50 AM    More...
FDA Approves New Indication For Berlex Inc.'s YAZ(R) To Treat Emotional And Physical Symptoms Of Premenstrual Dysphoric Disorder (PMDD) 10/5/2006 9:25:05 AM    More...
Berlex Inc. Issues Nationwide Recall Of A Single Lot Of Ultravist(R) Injection 370 mgI/mL, 125 mL In The U.S. 7/20/2006 6:37:20 PM    More...
Berlex Inc. Release: New Autoinjection Device Designed To Work With Betaseron(R) Now Available For Patients With Multiple Sclerosis 7/11/2006 11:06:38 AM    More...
Confirma, Inc. Products Now Available Through Berlex Inc.'s Accrual Program 5/22/2006 2:13:55 PM    More...
12345

//-->